Insulin, insulin-like growth factors-I and -II and insulin-like growth factor binding protein-3 in newborn serum: Association with normal fetal head growth and head circumference

Journal of Pediatric Endocrinology and Metabolism

Volumn 14, Issue 2, 2001, Pages 151-158

  Davidson, S ^a   Shtaif, B ^a   Gil Ad, I ^a   Maayan, R ^a   Sulkes, J ^a   Weizman, A ^a   Merlob, P ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

Fetal head growth; Insulin; Insulin like growth factor binding protein 3; Insulin like growth factors I and II

Indexed keywords

INSULIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; BODY HEIGHT; CONTROLLED STUDY; FETUS GROWTH; GESTATIONAL AGE; GROWTH HORMONE BLOOD LEVEL; HEAD CIRCUMFERENCE; HUMAN; HUMAN EXPERIMENT; INFANT; INSULIN BLOOD LEVEL; METHODOLOGY; NEWBORN; PRENATAL GROWTH; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS;

EID: 0035098527     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2001.14.2.151     Document Type: Article

References (36)

1. Causes of intrauterine growth restriction
2. Workshop summary: Fetal growth: Its regulation and disorders
3. The endocrine regulation of fetal growth in late gestation: The role of insulin-like growth factors
4. Growth factor regulation of fetal growth
5. Insulin-like growth factors
6. Insulin as a growth factor
7. Insulin cord levels in large for gestational age infants born to non-obese, non-diabetic mothers
8. What is the role of growth hormone and related peptides in implantation and the development of the embryo and fetus?
9. Somatomedin in cord blood: Relationship to gestational age and birth size
10. Insulin-like growth factors (IGF) 1 and 2 in human foetal plasma and relationship to gestational age and foetal size during midpregnancy
11. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus: Relationship with growth in normal subjects and in subjects with intrauterine growth retardation
12. C-peptide, insulin-like growth factor binding protein-1 in umbilical cord serum: Correlation with birth weight
13. Ontogeny of insulin-like growth factor binding protein-1, -2, and -3: Quantitative measurements by radioimmunoassay in human fetal serum
14. The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors
15. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth
16. Third trimester fetal growth and umbilical venous blood concentrations of IGF-I, IGFBPI and growth hormone at term
17. Insulin-like growth factors (IGFs) and IGF binding proteins-1, -2, and -3 in newborn serum: Relationship to fetoplacental growth at term
18. IGF-I, IGF-II, free IGF-I and IGFBP-I, II and -3 levels in venous cord blood: Relationship to birth weight, length and gestational age in healthy newborns
19. Maternal insulin sensitivity and cord blood peptides: Relationships to neonatal size at birth
20. Insulin-like growth factors, their binding proteins and macrosomia in offspring of non-diabetic pregnant women
21. Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-l, growth hormone and feeding in the newborn
22. Relationship of insulin-like growth factor-I, insulin-like growth factor binding protein-3, insulin, growth hormone in cord blood and maternal factors with birth height and birth weight
23. Growth hormone, somatomedin C and non-suppressible insulin-like activity levels compared in premature, small, average birth weight, and large infants
24. Growth hormone, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are regulated differently in small for gestational age and appropriate for gestational age neonates
25. The concentration of insulin-like growth factor I and insulin-like growth factor binding protein-1 in human umbilical cord serum at delivery: Relationship to fetal weight
26. Insulin-like growth factor-II and nonsuppressible insulin-like activity levels in newborns
27. Growth hormone, insulin-like growth factor-I and brain growth and function
28. Insulin-like growth factor-I -an important intrauterine growth factor
29. Effect of IGF-I and growth hormone on cell viability in primary mouse brain culture, and neuroblastoma cell-line. Evidence for anti-apoptotic mechanism for IGF-I
30. Growth enhancement of transgenic mice expressing human insulin-like growth factor I
31. Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice
32. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene
33. Expression of insulin-like growth factor in transgenic mice with elevated levels of growth hormone is correlated with growth
34. Brain growth retardation due to the expression of human insulin-like growth factor binding protein 1 (IGFBP-1) in transgenic mice: An in vivo model for the analysis of IGF function in the brain
35. Human insulin-like growth factor binding protein-1 (HIGFBP-1) in transgenic mice: Characterization and insights into the regulation of IGFBP-1 expression
36. In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: Studies of IGF-I and IGF binding protein-1 (IGFBP-1) in transgenic mice